Carnitine acetyltransferase deficiency mediates mitochondrial dysfunction-induced cellular senescence in dermal fibroblasts.

Aging is accompanied by impaired mitochondrial function and accumulation of senescent cells. Mitochondrial dysfunction contributes to senescence by increasing the levels of reactive oxygen species and compromising energy metabolism. Senescent cells secrete a senescence-associated secretory phenotype (SASP) and stimulate chronic low-grade inflammation, ultimately inducing inflammaging. Mitochondrial dysfunction and cellular senescence are two closely related hallmarks of aging; however, the key driver genes that link mitochondrial dysfunction and cellular senescence remain unclear. Here, we aimed to elucidate a novel role of carnitine acetyltransferase (CRAT) in the development of mitochondrial dysfunction and cellular senescence in dermal fibroblasts. Transcriptomic analysis of skin tissues from young and aged participants showed significantly decreased CRAT expression in intrinsically aged skin. CRAT downregulation in human dermal fibroblasts recapitulated mitochondrial changes in senescent cells and induced SASP secretion. Specifically, CRAT knockdown caused mitochondrial dysfunction, as indicated by increased oxidative stress, disruption of mitochondrial morphology, and a metabolic shift from oxidative phosphorylation to glycolysis. Mitochondrial damage induced the release of mitochondrial DNA into the cytosol, which activated the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) and NF-ĸB pathways to induce SASPs. Consistently, fibroblast-specific CRAT-knockout mice showed increased skin aging phenotypes in vivo, including decreased cell proliferation, increased SASP expression, increased inflammation, and decreased collagen density. Our results suggest that CRAT deficiency contributes to aging by mediating mitochondrial dysfunction-induced senescence.

The Assessment of Geometric Reliability of Conventional Trajectory of Ventriculostomy in a Three Dimensional Virtual Model and Proposal of a New Trajectory.

Ventriculostomy is a common neurosurgery procedure performed for many purposes. Kocher's point is most often used as the ventriculostomy entry point. But the accuracy of a cannula's trajectory into the ventricles from entry at Kocher's point is controversial. In this paper we attempt to evaluate the accuracy of the conventional sagittal trajectory, which uses Kocher's point, and evaluate a new trajectory by creating virtual ventriculostomy simulations from computed tomography images of the brain. About 66 patients without brain and skull pathology in radiography were included. Three dimensional images were constructed using thin sliced brain computed tomography images, and a virtual ventriculostomy was performed toward the previous used surface landmark. And the path of ideal ventricular catheter was simulated. The anterior surface landmarks included the ipsilateral medial canthus, the contralateral medial canthus, and the midpoint between bilateral medial canthi. The lateral surface landmark was the external auditory canal. The sagittal trajectory of the three surface landmarks located in the frontal horn of ipsilateral ventricle was 0% for the ipsilateral medial canthus, 87.88% for the midpoint between bilateral medial canthi and 26.52% for the contralateral medial canthus. The anterior surface target of ideal sagittal trajectory, which connects the Kocher's point with the central axis of ipsilateral ventricle, is contralaterally 6.7 mm away from midline. It was found that the conventional sagittal trajectory is inaccurate. The anterior target of surface landmark for the ideal sagittal trajectory is medial one third of the distance between the midline and the contralateral medial canthus.

IRF3 signaling pathway serves an important role in poly(I:C)-induced procollagen reduction in human skin fibroblasts.

Pattern recognition receptors (PRRs) are part of the immune system. They can recognize pathogen­associated molecular patterns (PAMPs). Toll­like receptors (TLRs) and retinoic acid­inducible gene 1 (RIG­1)­like receptors (RLRs) are 2 types of PRR in the innate immune system. Double­stranded RNA (dsRNA) can exist as a PAMP, including dsRNA viruses. dsRNA is known as a ligand not only for TLR3 but also for RLRs, including melanoma differentiation­associated gene 5 and RIG­1. Collagen is the main structural protein in the extracellular space in the skin. Recently, it was reported that treatment of a synthetic dsRNA, poly(I:C), decreases procollagen expression in skin fibroblasts. However, signaling pathways involved in this process have not yet been fully elucidated. The present study further explored the underlying signaling pathways involved in the processes. It was demonstrated by western blotting that treatment of poly(I:C), but not another PAMP, Pam3CSK4, inhibited procollagen expression in cultured human skin fibroblasts. Treatment of poly(I:C)and Pam3CSK4 induced activation of the mitogen­activated protein kinases and the nuclear factor­κB pathways. However, only poly(I:C), but not Pam3CSK4, induced the activation of the interferon regulatory factor 3 (IRF3) pathway. By using specific inhibitors, it was demonstrated that inhibition of IRF3 pathway relieved poly(I:C)­induced procollagen reduction. In conclusion, IRF3 signaling pathway serves an important role in poly(I:C)­induced procollagen reduction in skin fibroblasts. This suggests that the IRF3 signaling pathway may be a key target for collagen regulation in the skin.

A synthetic peptide blocking TRPV1 activation inhibits UV-induced skin responses.

BACKGROUND: Transient receptor potential type 1 (TRPV1) can be activated by ultraviolet (UV) irradiation, and mediates UV-induced matrix metalloproteinase (MMP)-1 and proinflammatory cytokines in keratinocytes. Various chemicals and compounds targeting TRPV1 activation have been developed, but are not in clinical use mostly due to their safety issues. OBJECTIVE: We aimed to develop a novel TRPV1-targeting peptide to inhibit UV-induced responses in human skin. METHODS: We designed and generated a novel TRPV1 inhibitory peptide (TIP) which mimics the specific site in TRPV1 (aa 701-709: Gln-Arg-Ala-Ile-Thr-Ile-Leu-Asp-Thr, QRAITILDT), Thr705, and tested its efficacy of blocking UV-induced responses in HaCaT, mouse, and human skin. RESULTS: TIP effectively inhibited capsaicin-induced calcium influx and TRPV1 activation. Treatment of HaCaT with TIP prevented UV-induced increases of MMP-1 and pro-inflammatory cytokines such as interleukin (IL)-6 and tumor necrosis factor-α. In mouse skin in vivo, TIP inhibited UV-induced skin thickening and prevented UV-induced expression of MMP-13 and MMP-9. Moreover, TIP attenuated UV-induced erythema and the expression of MMP-1, MMP-2, IL-6, and IL-8 in human skin in vivo. CONCLUSION: The novel synthetic peptide targeting TRPV1 can ameliorate UV-induced skin responses in vitro and in vivo, providing a promising therapeutic approach against UV-induced inflammation and photoaging.

Highly fluorescent resorcinarene cavitand nanocapsules with efficient renal clearance.

Nanomaterial based imaging approaches hold substantial promise in addressing current diagnostic and therapeutic challenges. One of the key requirements for the successful clinical translation of nanomaterials is their complete clearance from the body within a reasonable time period preferably via the renal filtration route. This article describes the synthesis of highly fluorescent, water soluble, resorcinarene cavitand nanocapsules and demonstrates their effective renal clearance in mice. The synthesis and functionalization of nanocapsules was accomplished in a one-pot operation via thiol-ene reactions without involving self-assembly, sacrificial templates or emulsions. Water soluble resorcinarene cavitand nanocapsules obtained by this approach were covalently functionalized with Alexa Fluor 750. Highly fluorescent nanocapsules with hydrodynamic diameters of 122 nm and 68 nm and extinction coefficients of 1.3 × 10(9) M(-1) cm(-1) and 1.5 × 10(8) M(-1) cm(-1) respectively were prepared by varying the reaction conditions. The in vivo biodistribution and clearance of these nanocapsules in mice followed by whole-body fluorescence imaging showed that they were both cleared renally within a few hours. Given the inherent encapsulation capabilities of nanocapsules, the renal clearance demonstrated in this work opens up new opportunities for their theranostic applications especially for targeting and treating the urinary tract.

Serum amyloid A1 secreted from UV-irradiated keratinocytes induces matrix metalloproteinase-1 in fibroblasts through toll-like receptor 4.

Ultraviolet (UV) irradiation on skin triggers photoageing-related phenotypes such as formation of wrinkles. UV ray upregulates matrix metalloproteinase-1 (MMP-1), which in turn degrades extracellular matrix proteins, mostly collagens. Serum amyloid A1 (SAA1) is an acute-phase protein of which plasma concentration increases in response to inflammation. Although the expression of SAA1 in the skin was reported, its function in the skin is yet to be studied. In this research, we found that the expression of SAA1 was increased in acute UV-irradiated buttock skin and photoaged forearm skin in vivo. UV irradiation also increased SAA1 in normal human epidermal keratinocytes (NHEK), and treatment of recombinant human SAA1 (rhSAA1) induced MMP-1 in normal human dermal fibroblasts (NHDF) but not in NHEK. Next, we demonstrated that NHDF treated with UV-irradiated keratinocyte-conditioned media showed the increased MMP-1 expression; however, this increase of MMP-1 in NHDF was inhibited by knockdown of SAA1 in NHEK. In addition, knockdown of Toll-like receptor 4 (TLR4) inhibited rhSAA1-induced MMP-1 expression in NHDF. Taken together, our data showed that UV-induced SAA1 production in NHEK, and this secreted SAA1 induced MMP-1 expression in NHDF in a paracrine manner through TLR4 signalling pathway. Therefore, our results suggest that SAA1 can be a potential mediator for UV-induced MMP-1 expression in human skin.

Multidentate ionic surfactant mediated extraction and dispersion of gold nanoparticles in organic solvents.

Resorcinarenes with three different quaternary ammonium headgroups were synthesized and evaluated for their ability to stabilize gold nanoparticles in organic and aqueous medium. Aqueous dispersions of citrate stabilized gold nanoparticles of dimensions up to 29 nm could be extracted into organic solvents by resorcinarenes functionalized with tetrapyridinium tetrabromide (1), tetratrimethylammonium tetrabromide (2), and tetratributylammonium tetrabromide (3). Such nanoparticles were characterized by TEM, EDS, UV-vis, and IR. Their long-term dispersion stability varied significantly and depended on the nature of the resorcinarene headgroup, and in particular nanoparticles extracted by resorcinarene 1 were stable for several weeks. Nanoparticles passivated by resorcinarenes 1 and 2 were also stable in the presence of thiourea for several hours in both aqueous and organic medium. This is notable as thiourea is known to result in the instantaneous aggregation of citrate stabilized nanoparticles. Remarkably nanoparticles stabilized by resorcinarenes 1 and 2 could be precipitated and redispersed in chloroform without any visible aggregation. The critical parameters controlling the extraction of the nanoparticles into the organic phase have also been evaluated. The resorcinarene surfactant mediated facile phase transfer of gold nanoparticles described here can be readily applied for the stabilization of other citrate stabilized mono- and bimetallic nanoparticles, thus providing opportunities to disperse and stabilize relatively larger nanoparticles in organic solvents using ionic surfactants opening up new applications.